Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.
|
11241838 |
2001 |
Atelosteogenesis type 2
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.
|
11448940 |
2001 |
Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.
|
11448940 |
2001 |
Atelosteogenesis type 2
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation.
|
10465113 |
1999 |
Atelosteogenesis type 2
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Identification of the Finnish founder mutation for diastrophic dysplasia (DTD).
|
10482955 |
1999 |
Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
BEFREE |
Here, we demonstrate that McAlister dysplasia arises from mutations in the diastrophic dysplasia sulfate transporter gene and that this disorder essentially coincides on molecular and biochemical grounds with atelosteogenesis type 2.
|
9342225 |
1997 |
Atelosteogenesis type 2
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.
|
9342225 |
1997 |
Atelosteogenesis type 2
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.
|
8571951 |
1996 |
Atelosteogenesis type 2
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene.
|
8528239 |
1996 |
Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
BEFREE |
Achondrogenesis type 1B (ACG-1B), atelosteogenesis type 2 (AO-2), and diastrophic dysplasia (DTD) are recessively inherited chondrodysplasias of decreasing severity caused by mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene on chromosome 5.
|
8723100 |
1996 |
Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
UNIPROT |
Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.
|
8571951 |
1996 |
Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.
|
8571951 |
1996 |
Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
BEFREE |
The presence of the DTDST R279W mutation in a total of 11 patients with AO2 or DTD emphasizes the overlap between these conditions.
|
8931695 |
1996 |
Atelosteogenesis type 2
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.
|
8931695 |
1996 |
Atelosteogenesis type 2
|
0.780 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Atelosteogenesis type 2
|
0.780 |
Biomarker
|
disease |
CTD_human |
|
|
|